Humanized
Drug Discovery

Welcome to Discovery Biomed
Integrating Human Cell Physiology with the Drug Discovery Critical Path.

Our Mission

DBM’s mission is to fill a critical niche within the modern drug discovery industry by specializing in custom human cell engineering and human cell-based drug discovery.

Our R&D infrastructure and know-how are leveraged as a CRO service to support the commercial and academic drug discovery community by integrating human cell research platforms at any and all points within the drug discovery critical path from HTS cell assay development and optimization to lead prioritization and progression, with the end product being ‘high value’ clinical candidates.

 

Latest News

Q4 2016 Update - DBM Participates at BIO’s 2016 International Conference and BIO’s 2016 Investor Forum, Continues an Active Intern Program
October 26, 2016

October 24th, 2016 by Dr. Erik Schwiebert In June 2016, DBM’s Dr. Erik Schwiebert and Dr. John Streiff, with support from our long-time consultant, Dr. Douglas Hay, traveled to San…

Read More »
DiscoveryBioMed, Inc. Declares a Sharpened Focus on Renal Cell Biology and Physiology and on Renal Diseases
February 15, 2016

Through both natural evolution of our R&D programs and within our CRO services business, DiscoveryBioMed, Inc. (DBM, Inc.) has identified a sharpening focus in Renal or Kidney Cell Biology and…

Read More »

Online Store

Human Cellular Toxicity Assay Panels

Learn More

Human Cell Cultures, Cell Lines and Specialty Media and Methods

Learn More

Custom CRO Services Program

Learn More